In the present study, we compared the effects of therapy with another once-weekly GLP-1 RA, i.e., semaglutide, with those of dulaglutide therapy and showed that semaglutide therapy was more effective than dulaglutide therapy in reducing the daily glucose variability following a 24-week treatment
In-utero exposure to DDT and pyrethroids and child behavioral and emotional problems at 2 years of age in the VHEMBE cohort, South Africa
FGF-21 also enhances glucose uptake during muscle activity by activating the P2Y/PI3K/AKT/mTOR pathway, further underscoring its role in exercise-induced metabolic benefits [269]
The Salt Form Controversy: Chemical Identity and Regulatory Evasion A critical battleground in the current GLP-1 litigation involves the chemical form of the active ingredient
Novo Nordisk has petitioned the FDA to add semaglutide to the Demonstrable Difficulties for Compounding (DDC) list, which would further restrict compounding
Baran N, Molina J, Cavazos A, Harutyunyan K, Feng N, Gay J, Piya S, Velandy SS, Jabbour EJ, Andreeff M , Tiziani S, Ferrando AA, Zweidler-McKay P, DiFrancesco ME, Marzalek JR, Konopleva M
